Matthew G. Vander Heiden, MD, PhD (Damon Runyon-Rachleff Innovator ‘11-‘13, Damon Runyon Fellow ‘06-‘08) of MIT, Cambridge, and colleagues, reported the results of a large study analyzing gene expression data from 22 tumor types. They identified multiple changes in genes that regulate metabolism in cancer cells. The analysis also identified hundreds of potential drug targets that could block tumor growth. The study was published in the journal Nature Biotechnology.
